Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...
A new report from scientists at the Centers for Disease Control and Prevention shows that infection rates from drug-resistant ...
The global HIV diagnostics market is expected to grow at a CAGR of ~10% during the forecast period. Rising prevalence of HIV ...
Zimbabwe has been chosen among 10 countries worldwide to introduce lenacapavir, an experimental HIV prevention drug that provides protection with just two ...
IN a major boost to the fight against HIV and Aids, Zimbabwe has been selected as one of the 10 countries globally to roll out lenacapavir, which is described as one of the most promising new HIV ...
A scientist at the Uganda Virus Research Institute and Research and Outreach Associate at Target Malaria, Krystal Birungi, ...